← Stocks · PPCB page
Price chart & company basics · Trifecta Signals
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
The Trifecta List
Propanc has never had a Trifecta signal in the record — not an Early signal, not a confirmed one — since the record began in January 2022. It is scanned after every trading day’s close along with the full US-listed universe; so far it has never met the conditions.
That’s the whole record for this stock: the chart and the basics above, and nothing to grade.
The list is the public track record: every stock that has signaled, logged, confirmed, and graded.
This page follows Propanc Biopharma, which trades under the PPCB ticker.
Across the past year, closes have spanned $1.71 to $295, and the latest close sits near the bottom of that span. The low-to-high span over the year comes to about 17151%. Price history on this page reaches back to January 2018.
The stock closed Wednesday, November 4 at $1.79, up 4.7% on the day. Recent trading has kept the shares between about $1.71 and $2.11 over the past week.
